U.S. Markets open in 7 hrs 17 mins

Acura Pharmaceuticals, Inc. (ACUR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.44+0.02 (+4.51%)
At close: 3:49PM EDT
People also watch
ABIOAPRIALIMCLSNAEZS
  • o
    ordr
    ordr

    This nasdaq stock could be on the verge of greatness. https://seekingalpha.com/article/4045084-long-island-iced-tea-looks-poised-benefit-shift-away-carbonated-beverages

    Long Island Iced Tea Looks Poised To Benefit From Shift Away From Carbonated Beverages
    Long Island Iced Tea is a beverage company that provides premium non-alcoholic ready-to-drink iced tea bottle beverages. The company recently closed a public of
    seekingalpha.com
  • E
    Eric
    Eric
    $ACUR,$LINU
  • F
    Felike
    Felike

    www.PennySt0ckl0l.org is one of the best “alerts” services I have found. Just sign up and watch from the sidelines, you will see!

  • D
    Dave
    Dave
    Imagecovvchop
  • D
    Dave
    Dave
    Imagemavietresgaie
  • D
    Dave
    Dave
    Imagegeekylaugifs
  • D
    Dave
    Dave
    Imagegif-007
  • t
    tom
    tom

    Monster MicroCaps SPECIAL ALERT to ACUR shareholders – NWBO $.19 and climbing, just announced $11 million financing with convertible debt payable in 3 years at $0.25, $.50 and $1.00. NWBO expected to release final Phase III Trial results any day from now until mid-July. If results are comparable to preliminary data, shares likely to explode to yield enormous percentage gains. Announcement could be huge because DCVax-L and DCVax Direct are also proven effective against 13 common cancers and has only mild fever as potential side effect. This breakthrough immunotherapy might replace the $100 Billion chemotherapy market.
    https://finance.yahoo.com/news/nwbio-closes-3-convertible-debt-154100683.html

  • r
    robert
    robert
    Any idea when the latest trial for the FDA will begin? I am assuming it will be sometime this month with results back in the following 2-3 week. Any thoughts????
  • G
    GamerzX
    GamerzX
    when this board is dead like it used to before
  • A
    Anonymous
    Anonymous

    Found a great no fee daytrading newsletter, vist www.T0pm@rketgainers.c0m and sign up...so glad I did

  • A
    Anonymous
    Anonymous

    I also received an alert for $ACUR from http://monstastocks.com/?s=ACUR , any ideas? Remember Investing making money.

    Monsta Stocks: Trading Stocks and Making Money
    Stock alerts from the Monsta Stocks. Stock trading, making money and always looking for the next big money maker.
    monstastocks.com
  • A
    Anonymous
    Anonymous

    He who does not hope to win has already lost. http://dataunion.tistory.com/1040

    [2016-MAY] Acura Pharmaceuticals NASDAQ : ACUR Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.8 In other words, the correlation coefficient of the other stoc
    dataunion.tistory.com
  • C
    Chase4
    Chase4
    I am buying here.
  • P
    Paul
    Paul
    Any idea where one can find the earnings report that should be coming out today?
  • P
    Peter
    Peter
    One day we will wake up and ACUR will be listed for 2.20 a share. Looking forward to that One day. :.)
  • P
    Peter
    Peter
    Probably just seen a bounce back. Still waiting on news about their strategic alternative options. I'm hoping for a sale of the company, probably for the best.
  • A
    Anonymous
    Anonymous
    Largest Gainers on the NASDAQ & NYSE ---> T0pMarketGalners.c0m
  • P
    Peter
    Peter
    Well we are officially on the OTC Board. Not Ideal, but I think (I hope) they are trying to find a buyer. Still holding tight, and seems I'm not alone.

    February 22, 2017 Kevin B. Atencio
    The Brokerages Anticipate Acura Pharmaceuticals, Inc. (ACUR) to Post ($0.27) Earnings Per Share
    Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) has received an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.
  • r
    robert
    robert
    Needless to say, not happy with where this stock is currently trading! On the other hand, if you make a public statement that you have hired an IB to search alternatives, I would assume they will be able to get far more than .77! They have enough critical patents that the value of the stock should be in the $4-5 range - maybe more depending on who the buyer is. Just as critical question, "Are the parts worth more than the whole?" I am hoping they don't get greedy and simply move this POS down the road - preferably for stock in a much better run company...........